Sarvodaya Hospital, Faridabad Becomes India’s First Theranostics Center to Offer Terbium-161 PSMA Therapy for Advanced Prostate Cancer Patients

Sarvodaya Hospital: Leading the Charge in Advanced Cancer Treatment

In a significant leap forward, Sarvodaya Hospital in Faridabad, Delhi NCR, has become the first center in India to offer Terbium-161 PSMA therapy for prostate cancer. This pioneering move marks a pivotal moment in cancer care, setting a new standard for treatment options.

The Dawn of Theranostics: Precision Oncology Takes Center Stage

Theranostics, a groundbreaking approach, combines diagnostic imaging with targeted therapy. Terbium-161 PSMA therapy exemplifies this by targeting cancer cells with remarkable precision. This means fewer side effects and a more effective fight against the disease, especially for those with advanced metastatic castration-resistant prostate cancer.

Did you know? Prostate cancer is a leading cause of cancer deaths in men. This innovative therapy offers renewed hope for patients who haven’t responded to other treatments.

CAR-T Cell Therapy: Revolutionizing Blood Cancer Treatment

Adding to its comprehensive cancer care offerings, Sarvodaya Hospital has also introduced CAR-T Cell therapy for blood cancers like leukemia, lymphoma, and multiple myeloma. This cutting-edge treatment involves re-engineering a patient’s own immune cells to attack cancer cells.

Pro Tip: Early diagnosis and access to advanced treatments are crucial. Consult with your doctor if you suspect you have any symptoms associated with cancer.

The Future of Cancer Care: A Holistic Approach

Sarvodaya Hospital’s commitment to integrated care – from diagnosis to advanced treatments – mirrors a broader trend in healthcare. The ability to provide multiple therapies under one roof simplifies the patient experience and fosters better outcomes.

“The introduction of this groundbreaking therapy in India will bring renewed hope to patients battling advanced prostate cancer,” states Dr. Swagat Dash, HOD & Senior Consultant – Nuclear Medicine, Sarvodaya Cancer Institute. His words highlight the positive impact of these advancements.

The hospital’s investment in advanced technology alongside experienced specialists promises a future where cancer treatment is more effective, personalized, and accessible. The hospital’s adoption of Terbium-161 PSMA therapy shows a commitment to stay ahead of the curve. Explore other advanced cancer treatments here.

Key Takeaways: What This Means for Patients

• Precision Matters: Theranostics offers targeted treatment, reducing side effects.
• Hope for Advanced Cases: New therapies are available for patients who haven’t responded to traditional treatments.
• Comprehensive Care: Hospitals are providing integrated services for better patient outcomes.

Dr. Dinesh Pendharkar, Director, Sarvodaya Cancer Institute, highlights, “We are shifting the landscape in terms of what complete cancer care means with CAR-T Cell therapy as well as Theranostics.”

If you are looking for more information about cancer care or need a consultation, reach out to Sarvodaya Hospital here.

FAQ

What is Theranostics? Theranostics combines diagnostic imaging with targeted therapy to treat cancer cells precisely.

What is CAR-T Cell therapy? CAR-T Cell therapy involves re-engineering a patient’s immune cells to attack cancer cells.

Why is Sarvodaya Hospital’s announcement significant? They are the first in India to offer Terbium-161 PSMA therapy and offer both Theranostics and CAR-T Cell therapy.

Where is Sarvodaya Hospital located? Sarvodaya Hospital is located in Faridabad, Delhi NCR.

What are your thoughts on these groundbreaking developments? Share your comments and insights below!